These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 9760435)
41. [Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases]. Flisiak R; Pancewicz S; Przegl Epidemiol; 2008; 62(1):193-9. PubMed ID: 18536243 [No Abstract] [Full Text] [Related]
42. Sero-epidemiological study of Lyme disease among high-risk population groups in eastern Slovakia. Zákutná Ľ; Dorko E; Mattová E; Rimárová K Ann Agric Environ Med; 2015; 22(4):632-6. PubMed ID: 26706967 [TBL] [Abstract][Full Text] [Related]
43. Recent lesson from a clinical and seroepidemiological survey: low positive predictive value of Borrelia burgdorferi antibody testing in a high risk population. Lakos A; Igari Z; Solymosi N Adv Med Sci; 2012; 57(2):356-63. PubMed ID: 23314562 [TBL] [Abstract][Full Text] [Related]
44. Seroepidemiological study of Lyme borreliosis among forestry workers in southern Poland. Buczek A; Rudek A; Bartosik K; Szymanska J; Wojcik-Fatla A Ann Agric Environ Med; 2009; 16(2):257-61. PubMed ID: 20047259 [TBL] [Abstract][Full Text] [Related]
45. [Prevalence of Borrelia burgdorferi serum antibodies in 651 patients with predominantly neurologic diseases]. Müller M; Retzl J; Plank E; Scholz H; Ziervogel H; Stanek G Wien Klin Wochenschr; 1993; 105(21):599-602. PubMed ID: 8273357 [TBL] [Abstract][Full Text] [Related]
46. Prevalence of antibodies to Borrelia burgdorferi in European bison (bison bonasus) from Białowieza Primeval Forest. Siński E; Gill J; Rijpkema S Rocz Akad Med Bialymst; 1996; 41(1):111-6. PubMed ID: 8673795 [TBL] [Abstract][Full Text] [Related]
47. Antibody response to OspC-I synthetic peptide derived from outer surface protein C of Borrelia burgdorferi in sera from Japanese forestry workers. Ikushima M; Yamada F; Kawahashi S; Okuyama Y; Matsui K Epidemiol Infect; 1999 Jun; 122(3):429-33. PubMed ID: 10459646 [TBL] [Abstract][Full Text] [Related]
48. [Assessment of antioxidative defense parameters in serum and age of patients showing antibodies anti-Borrelia burgdorferi presence--non-symptomatic carriers]. Pancewicz SA; Skrzydlewska E; Hermanowska-Szpakowicz T; Makieła M; Kondrusik M; Zajkowska J; Grygorczuk S; Swierzbińska R Przegl Epidemiol; 2006; 60 Suppl 1():102-8. PubMed ID: 16909786 [TBL] [Abstract][Full Text] [Related]
49. Prevalence of antibodies to Borrelia burgdorferi in forestry workers of Ile de France, France. Zhioua E; Rodhain F; Binet P; Perez-Eid C Eur J Epidemiol; 1997 Dec; 13(8):959-62. PubMed ID: 9476828 [TBL] [Abstract][Full Text] [Related]
50. [Seasonal prevalence of antibodies against Borrelia burgdorferi in Białowiez inhabitants]. Flisiak R; Wiercińska-Drapało A; Prokopowicz D; Flisiak I Przegl Epidemiol; 1995; 49(3):251-6. PubMed ID: 7491419 [TBL] [Abstract][Full Text] [Related]
51. Detection of Borrelia burgdorferi sensu lato DNA in Ixodes ricinus ticks in North-western Poland. Wodecka B Ann Agric Environ Med; 2003; 10(2):171-8. PubMed ID: 14677908 [TBL] [Abstract][Full Text] [Related]
52. [The survey of prevalence of Lyme borreliosis in forestry workers in Saitama prefecture]. Ikushima M; Kawahashi S; Okuyama Y; Matsui K; Arai T Kansenshogaku Zasshi; 1995 Feb; 69(2):139-44. PubMed ID: 7745287 [TBL] [Abstract][Full Text] [Related]
53. Detection of Borrelia burgdorferi sensu lato DNA by PCR in serum of patients with clinical symptoms of Lyme borreliosis. Santino I; Berlutti F; Pantanella F; Sessa R; del Piano M FEMS Microbiol Lett; 2008 Jun; 283(1):30-5. PubMed ID: 18384365 [TBL] [Abstract][Full Text] [Related]
54. Seasonal prevalence of antibodies against Borrelia burgdorferi in Białowieza inhabitants. Flisiak R; Wiercińska-Drapało A; Kalinowska A; Prokopowicz D Rocz Akad Med Bialymst; 1996; 41(1):96-102. PubMed ID: 8673812 [TBL] [Abstract][Full Text] [Related]
55. [Prevalence of Borrelia burgdorferi antibodies in healthy population in Poland]. Chmielewski T; Tylewska-Wierzbanowska S Przegl Epidemiol; 2002; 56(1):33-8. PubMed ID: 12150065 [TBL] [Abstract][Full Text] [Related]
56. [Clinical course of Lyme borreliosis with respect to the initial disease manifestation in Białowieza residents]. Flisiak R; Załezny W; Prokopowicz D Przegl Epidemiol; 2004; 58(3):445-50. PubMed ID: 15730008 [TBL] [Abstract][Full Text] [Related]
57. Seroprevalence of Borrelia burgdorferi in forest workers from inspectorates with different forest types in Lower Silesia, SW Poland: preliminary study. Kiewra D; Szymanowski M; Zalewska G; Dobracka B; Dobracki W; Klakočar J; Czułowska A; Plewa-Tutaj K Int J Environ Health Res; 2018 Oct; 28(5):502-510. PubMed ID: 29963907 [TBL] [Abstract][Full Text] [Related]
58. Borrelia burgdorferi antibodies in outdoor and indoor workers in south-west Sweden. Werner M; Nordin P; Arnholm B; Elgefors B; Krantz I Scand J Infect Dis; 2001; 33(2):128-31. PubMed ID: 11233848 [TBL] [Abstract][Full Text] [Related]
59. [Clinical course of borreliosis in children]. Andrzejewski A; Woźniakowska-Gesicka T; Kmieć K; Sass-Just M Pol Merkur Lekarski; 2002 Jan; 12(67):54-6. PubMed ID: 11957805 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of an internally controlled real-time PCR targeting the ospA gene for detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid. Gooskens J; Templeton KE; Claas EC; van Dam AP Clin Microbiol Infect; 2006 Sep; 12(9):894-900. PubMed ID: 16882295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]